TBRG · As filed with the SEC

TruBridge income statement, by fiscal year

The statement as TruBridge presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF OPERATIONS · USD thousands, except per-share amounts; shares in thousands

USD thousands, except per-share amounts; shares in thousands	FY2025 Year ended Dec 31, 2025	FY2024 Year ended Dec 31, 2024	FY2023 Year ended Dec 31, 2023	FY2022 Year ended Dec 31, 2022	FY2021 Year ended Dec 31, 2021	FY2020 Year ended Dec 31, 2020	FY2019 Year ended Dec 31, 2019	FY2018 Year ended Dec 31, 2018
Revenues:
Total revenues	346,836	342,646	339,435	326,648	280,629	264,488	274,634	280,411
System sales and support	—	—	—	—	143,109	152,954	165,352	180,164
TruBridge	—	—	—	—	137,520	111,534	109,282	100,247
Revenue cycle	—	—	—	179,870	—	—	—	—
Electronic health record	—	—	—	139,823	—	—	—	—
Patient engagement	—	—	—	6,955	—	—	—	—
RCM	—	—	193,929	—	—	—	—	—
EHR	—	—	138,063	—	—	—	—	—
Patient engagement	—	—	7,443	—	—	—	—	—
Financial Health	221,657	217,672	—	—	—	—	—	—
Patient Care	125,179	124,974	—	—	—	—	—	—
Expenses:
System sales and support	—	—	—	—	—	—	—	75,984
TruBridge	—	—	—	—	—	—	—	54,699
Total costs of revenue (exclusive of amortization and depreciation)	162,974	168,531	175,868	172,213	139,747	128,242	130,489	130,683
System sales and support	—	—	—	—	70,664	69,361	73,872	—
TruBridge	—	—	—	—	69,083	58,881	56,617	—
Revenue cycle	—	—	—	97,010	—	—	—	—
Electronic health record	—	—	—	71,347	—	—	—	—
Patient engagement	—	—	—	3,856	—	—	—	—
Gross profit	—	—	—	154,435	140,882	136,246	144,145	149,728
RCM	—	—	110,192	—	—	—	—	—
EHR	—	—	62,048	—	—	—	—	—
Patient engagement	—	—	3,628	—	—	—	—	—
Financial Health	113,891	116,891	—	—	—	—	—	—
Patient Care	49,083	51,640	—	—	—	—	—	—
Product development	32,557	34,456	37,246	30,926	30,389	33,457	36,861	36,371
Sales and marketing	23,509	27,059	28,049	27,131	21,978	24,185	27,774	30,713
General and administrative	80,687	76,992	76,153	56,192	50,022	46,129	43,921	47,275
Amortization of acquisition-related intangibles	—	—	—	17,403	13,786	11,421	11,006	10,487
Total operating expenses	—	—	—	131,652	116,175	115,192	119,562	124,846
Amortization	25,185	27,627	24,522	—	—	—	—	—
Depreciation	1,092	1,346	1,946	—	—	—	—	—
Goodwill impairment	0	0	35,913	—	—	—	0	0
Trademark impairment	0	0	2,342	—	—	—	—	—
Total expenses	326,004	336,011	382,039	—	—	—	—	—
Operating income (loss)	20,832	6,635	(42,604)	22,783	24,707	21,054	24,583	24,882
Other (expense) income:
Other income	—	—	745	1,178	1,529	1,494	807	803
Gain on contingent consideration	—	—	—	565	0	0	5,000	—
Gain on contingent consideration	—	—	0	—	—	—	—	—
Loss on extinguishment of debt	—	—	0	(125)	0	(202)	0	0
Interest expense	—	—	(12,521)	(6,320)	(3,160)	(3,562)	(6,694)	(7,577)
Interest expense	(12,316)	(16,169)	—	—	—	—	—	—
Other (expense) income	(4,647)	(670)	(11,776)	(4,702)	(1,631)	(2,270)	(887)	(6,774)
Income before taxes	—	—	—	—	—	18,784	23,696	18,108
Total other expense	(16,963)	(16,839)	—	—	—	—	—	—
Income (loss) before taxes	3,869	(10,204)	(54,380)	18,081	23,076	—	—	—
(Benefit) provision for income taxes	(485)	10,235	(8,591)	2,214	4,646	4,538	3,228	476
Net income (loss)	4,354	(20,439)	(45,789)	15,867	18,430	14,246	20,468	17,632
Net income (loss) per share - basic (in dollars per share)	0.29	(1.38)	(3.15)	1.08	1.26	0.98	1.43	1.26
Net income (loss) per share - diluted (in dollars per share)	0.29	(1.38)	(3.15)	1.08	1.26	0.98	1.43	1.26
Weighted average shares outstanding used in per common share computations:
Basic (in shares)	14,488	14,300	14,187	14,356	14,290	14,038	13,778	13,561
Diluted (in shares)	14,488	14,300	14,187	14,356	14,318	14,038	13,778	13,568

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.